Table 2

Local inflammation at the inoculation site

Maximum diameter of erythema and/or induration (cm)a
A. Patients receiving 107 pfu of rV-CEA per dose
Group 1 (intradermal injection)Group 2 (Biojector)
Patient no.24569137810
Postprime3a2P1P32P564P2P1P
Postboost2112213221
B. Patients receiving 108 pfu of rV-CEA per dose
Group 3 (intradermal injection)Group 4 (Biojector)
Patient no.11131718201214151619
Postprime4P3P4P4P3P57P6P6P3P
Postboost2251002011
  • a Values are the maximum diameter (cm) of erythema and/or induration at the inoculation site 3–7 days following the dose. P, pustule formation.